Submitted by Anonymous (not verified) on 17 January 2025 - 16:08
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Status: Authorised